MedTrace Logo

Predictors of Sorafenib Response in HCC

NCT05967429 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2023-08-01

No results posted yet for this study

Summary

Evaluating the nutrition status of patients with advanced HCC who received sorafenib.

Using the pretreatment nutrition status and quality of life as predictors to sorafenib response

Conditions

Interventions

DIAGNOSTIC_TEST

The neutrophil-to- lymphocyte ratio

It was calculated by dividing the neutrophil count by the lymphocyte count.

DIAGNOSTIC_TEST

Prognostic nutrition index

It was calculated using the following formula: serum albumin (g/L) + 0.005 × total lymphocyte count/μL

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Principal Investigators

  • Amr Zagloul, MD · Sohag University

  • Ahmed othman, MD · Sohag University

  • Rafat Abd El Aal, MD · Sohag University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-31
Primary Completion
2024-04-30
Completion
2024-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05967429 on ClinicalTrials.gov